AIDS Healthcare Foundation: Vaccinate Our World Campaign - Europe Press Launch Virtual Press Conference 2-3pm GMT, 18 May 2021
Baroness Sheehan, the UK All-Party Parliamentary Group on Vaccinations for All
MEP Dr.
AHF Africa Bureau Chief
Zoya Shabarova
JOIN: Register for the virtual press conference here and pre submit questions for the Q&A
PRESS ENQUIRES: Jenny Rose jenny.rose@barleycommunications.co.uk +44 (0) 7957 551697, Ged Kenslea, AHF, ged.kenslea@ahf.org +1.323.791.5526
ALL ASSETS: Available for download from PA Media Centre We are facing a catastrophic moral and public health failure akin to the initial and woefully inadequate global response to the AIDS pandemic in the 1980s and 90s by allowing COVID-19 to rip through the world s poorest populations. We simply cannot make the same mistakes that were made in fighting HIV there must not be a delay in getting lifesaving vaccines to all corners of the globe, said
Wealthy Nations’ Vaccine Spree Obscures Global Covid Misery
Bloomberg 1 hr ago James Paton
(Bloomberg) Mass vaccinations, falling case counts and waning coronavirus deaths in a few wealthy countries threaten to obscure ongoing worldwide suffering from the pandemic that’s likely to last for months, and perhaps years, to come.
Popular Searches
That’s Carl Bildt’s worry as the new special envoy to the World Health Organization-backed effort set up last year to dispatch vaccines and other weapons against Covid-19. Suppressing the virus that’s advancing in India and beyond depends on persuading rich nations to share excess doses and help close a $19 billion funding gap, Bildt said in an interview.
Wealthy Nations’ Vaccine Spree Obscures Global Covid Misery
Bloomberg 5/13/2021 James Paton
(Bloomberg) Mass vaccinations, falling case counts and waning coronavirus deaths in a few wealthy countries threaten to obscure ongoing worldwide suffering from the pandemic that’s likely to last for months, and perhaps years, to come.
Popular Searches
That’s Carl Bildt’s worry as the new special envoy to the World Health Organization-backed effort set up last year to dispatch vaccines and other weapons against Covid-19. Suppressing the virus that’s advancing in India and beyond depends on persuading rich nations to share excess doses and help close a $19 billion funding gap, Bildt said in an interview.
“I don’t see a lot going well for them at this point,” said one analyst.
A participant in Novavax’s Phase 3 trials at Howard University in Washington earlier this year.Credit.Kenny Holston for The New York Times
May 11, 2021
Novavax, one of the first players in the race to vaccinate the world against Covid, delivered disheartening news on Monday, saying that its highly protective vaccine would not be authorized in the United States or Britain until at least July, and that it would not reach peak production until the end of the year.
The delays, announced during an earnings call with investors, are the latest setback for the little-known Maryland company, which was granted up to $1.6 billion from the U.S. federal government last year and whose product has shown robust results in clinical trials. Despite these wins, the company has struggled to demonstrate that it can deliver on its promise to supply the world with 2 billion doses this year. Novavax has never brought a vacc